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MinireviewThe IL-12 Family of Heterodimeric
Cytokines: New Players in the
Regulation of T Cell Responses
the heterodimer when p40 is also produced by the same
cells. IL-12 is a potent inducer of interferon- (IFN-)
production from T, NK, and other cell types, and it has
been shown to be a potent inducer of differentiation of
T helper 1 (Th1) cells. A very large number of studies in
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experimental animals, using genetically deficient ani-France
mals or neutralizing antibodies, have shown that IL-12,2 Department of Discovery Biology
due to its Th1-inducing activity, is required for resistanceDNAX Research Institute
to bacterial and intracellular parasite infections and forPalo Alto, California 94304
the establishment of organ-specific autoimmunity (Trin-
chieri, 2003). However, patients with complete defi-
ciency of IL-12 p40 chain or the IL-12R1 chain of itsOriginally the only known heterodimeric cytokine, IL-
receptor complex have a limited susceptibility to myco-12 is now part of a family of five cytokines and shares
bacteria or salmonella infections only, not the expectedimportant functions in the regulation of both innate
complete lack of resistance to most infections (Fieschiand adaptive immunity with two of them, IL-23 and IL-
and Casanova, 2003). Also, in the mouse, IL-12 was27. Although initially these three cytokines were con-
shown not to be required for Th1 responses, althoughsidered to have largely overlapping immunological
its expression was essential for optimal responses (Jan-functions, more recent studies, including two articles
kovic et al., 2002).in this issue of Immunity (Hamano et al., 2003; Villarino
For more than 10 years, IL-12 has remained the onlyet al., 2003), indicate that they mediate complex and
known heterodimeric cytokine. However, recently, it haswell-differentiated functions.
been joined by four new cytokines with a similar struc-
ture to form a family of heterodimeric cytokines (FigureWhen the cytokine Interleukin-12 (IL-12) was first puri-
1). Within the neuropoietic cytokines of the IL-6 family,fied in 1989, it was discovered, unlike all other known
CNTF was known to associate with the soluble extracel-cytokines, to have the unique molecular structure of a
lular part of its specific receptor (sCNTFR) to form acovalently linked heterodimer composed of two chains,
biologically active heterodimer signaling through a re-p40 and p35 (Trinchieri, 2003). The sequence of p35 is
ceptor complex composed of gp130 and leukemia inhib-homologous to that of IL-6 and G-CSF and indicates a
itory factor receptor (LIRF). More recently, it was foundfour--helix bundle structure, typical of cytokines. The
that CNTFR induces the secretion and is required forsequence of the p40 chain is homologous to the extra-
functional responses to the cardiothrophin-like cytokinecellular portion of members of the hemopoietin receptor
(CLC) (Lelievre et al., 2001). CLC can be secreted eitherfamily, particularly IL-6 receptor  chain (IL-6R) and
in association with sCNTFR or with another soluble cyliary neutrotrophic factor receptor (CNTFR). The ex-
receptor-homolog, the cytokine-like factor-1 (CLF-1),tracellular portions of the receptor  chain of the IL-6
thus forming two different heterodimeric cytokines.family of cytokines (e.g., IL-6, IL-11, CNTF) can be se-
sCNTFR/CLC is active on cells expressing gp130 andcreted as soluble molecules able to form complexes
LIFR, whereas CLC/CLF-1 requires also the presencewith the cytokines. These complexes bind to the other
of the transmembrane CNTFR.
transmembrane chains of the receptor complex (usually
IL-12 p40 was shown to associate not only with the
containing the gp130 -receptor chain), inducing signal
IL-12 p35 chain, but also with a p19 chain to form a
transduction. Thus, it was proposed that IL-12 evolved novel covalently linked heterodimeric cytokine, IL-23.
by a cytokine of the IL-6 family covalently bound to the p19, like p35, has homology with IL-6 and G-CSF, and
extracellular portion of its primordial  chain receptor is secreted only when associated with IL-12 p40 (Opp-
(Trinchieri, 2003). The membrane receptor complex of mann et al., 2000). The IL-23 receptor complex is com-
IL-12 is formed by the two chains IL-12R1 and IL- posed of IL-R1 and of a novel gp130-like chain, the
12R2, which are homologous to gp130. IL-12R1 binds IL-23R (Parham et al., 2002). Similarly to IL-12, IL-23
IL-12 p40, and it is associated with Tyk2, whereas IL- signaling activated Tyk2, Jak2, and STAT 1, 3, 4. How-
12R2 recognizes either the heterodimer or the p35 ever, the activation of STAT4 is not as predominant as
chain and is associated with Jak2. Signaling through for IL-12, and STAT3/4 heterodimers, rather than STAT4
the IL-12 receptor complex induces phosphorylation, homodimers, are induced by IL-23. IL-23 is produced
dimerization, and nuclear translocation of several STAT by similar cell types as IL-12, and the receptor complex
transcription factors (1, 3, 4, 5), but the predominant is expressed or upregulated on T and NK cells, as well
response and most of the biological responses to IL-12 as phagocytic and dendritic hematopoietic cells. IL-23
are mediated by STAT4 (Trinchieri, 2003). IL-12 is mostly has been proposed to have similar but not overlapping
produced by activated hematopoietic phagocytic cells functions with IL-12 in inducing IFN- production, T
(monocytes, macrophages, neutrophils) and dendritic helper 1 (Th1) cell differentiation, and activation of the
cells. IL-12 p40 is often secreted in large excess over antigen-presenting functions of dendritic cells (Parham
the p70 heterodimer; p35 is only secreted as a part of et al., 2002). Unlike IL-12, which is a relatively poor T cell
mitogen preferentially affecting naive T cells, IL-23 se-
lectively induces proliferation of memory T cells.*Correspondence: giorgio.trinchieri@spcorp.com
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Figure 1. Schematic Depiction of the Family of Heterodimeric Cytokines, Their Receptors, and Main Signaling Pathways
Epstein Barr virus-induced protein 3 (EBI3), an The discovery of IL-23 and IL-27, two cytokines that
affect IFN- production by T and NK cells and that, in-receptor-like soluble chain homologous to IL-12 p40,
was known for several years, and it has been suggested the case of IL-23, share with IL-12 part of the receptor
complex and of the signaling pathway, has contributedthat it also induces secretion of the p35 and associates
with it to form a noncovalently linked heterodimer (Trin- to challenge an essential role for IL-12 in Th1 differentia-
tion. Even in mice genetically deficient for IL-12 p40, IL-chieri, 2003). However, the physiologic relevance of this
observation was unclear, and no biological function has 12R1, or STAT4, the Th1 response is not completely
absent and can be recovered at levels sufficient forbeen associated with the EBI3-p35 heterodimer. More
recently, it was shown that EBI3 induces the secretion protection to intracellular infections when antiinflamma-
tory inhibitory pathways such as those mediated by IL-of a novel cytokine-like chain, p28, together with which
it forms a noncovalently linked heterodimeric cytokine 10 are prevented (Jankovic et al., 2002). The finding that
IL-12 is either unable or poorly efficient in inducing thenow termed IL-27 (Pflanz et al., 2002). Within the family
of long-chain four-helix bundle cytokines, p28 is evolu- expression of the transcription factor T-bet, considered
to be one of the earliest molecular events leading totionary closer to IL-11, CLC, CNTF, and LIF than to IL-6,
G-CSF, p35, and p19. One chain of the IL-27 receptor commitment of T cells to Th1 differentiation and able to
upregulate IL-12R2, has led to the hypothesis that IL-complex is the orphan receptor WSX-1/TCCR. Studies
with WSX-1 genetically deficient mice had associated 12 is required more for the expansion and optimal activa-
tion of Th1 cells rather than for the initiation of the Th1this receptor with IFN- production and Th1 responses
(Chen et al., 2000; Yoshida et al., 2001). Recently, the response (Mullen et al., 2001). T-bet expression is de-
pendent on STAT1, and it is efficiently induced by cyto-second chain of the IL-27 receptor complex has been
identified to be gp130 (S.P. et al., submitted). IL-27 acti- kines that efficiently activate STAT1 such as IFN-, type
I IFN, and IL-27. Th1 responses are completely abolishedvates Jak1, STAT1, and STAT3. IL-27 is produced by
human phagocytic and dendritic cells rapidly after acti- and Th2 responses are enhanced only in mice deficient
for the adaptor molecule MyD88, which is essential forvation, possibly earlier than the IL-12 heterodimer. IL-
27 synergizes with IL-12 in inducing IFN- production signal transduction in response to the IL-1 family of
cytokines (including the IL-1s and IL-18) and for most ofby T and NK cells, and it is a very potent mitogen for
anti-CD3 activated naive T cells. the signal transduction in response to Toll-like receptor
Minireview
643
(TLR) ligands (Jankovic et al., 2002). This suggests that allowed the identification of IL-23 p19 production in the
skin, and its ability to induce skin lesions, suggesting ain addition to IL-12 (and IL-23), other proinflammatory
cytokines or signals are important for Th1 response, role of IL-23 in cutaneous immunity (Kopp et al., 2003).
WSX-1/TCCR genetically deficient mice show a sus-possibly including IL-27 and the IL-1 family.
On the basis of the early known biology of IL-12, IL- ceptibility to Leishmania major and Listeria monocyto-
genes infection associated with defective or delayed23, and IL-27, a tentative model has emerged that IL-
27, by inducing T-bet expression, IL-12R2 chain ex- Th1 response, supporting a role for IL-27 in the initiation
of the Th1 response (Chen et al., 2000; Yoshida et al.,pression, and proliferation of naive T cells, would be
an early inducer of Th1 commitment and differentiation 2001). However, although the early IFN- production in
response to antigen or even IL-12 was decreased infollowed by expansion and stabilization of the Th1 re-
sponse by IL-12, and then by maintenance of Th1 com- CD4 T cells from WSX-1/ mice, upon secondary re-
stimulation CD4 T cells from WSX-1/ mice producedmitted memory cells by IL-23, a cytokine able to sustain
proliferation of memory T cells. However, recent findings slightly higher levels of IFN- than those from wt mice.
Similarly, in L. major-infected mice, CD4 T cells fromand ongoing studies are seriously questioning such a
simple model. WSX-1/ mice produced much lower IFN- than wt
mice at 2 weeks, but at 4 weeks there was no differenceThe discovery of IL-23, which shares the p40 chain
and the IL-12R1 chain with IL-12 and its receptor com- between the two groups of mice and, although the foot-
pad lesion did not heal, the progression of the infectionplex, has started to provide an explanation to the numer-
ous observations existing in the literature of the different was halted. These data are not consistent with a major
role of IL-27 in the initiation of the Th1 response butphenotypes of IL-12 p40- and IL-12R1-deficient mice
compared to those of IL-12 p35- or IL-12R2-deficient rather with an ability to affect the early inflammatory
IFN- production without significantly affecting commit-mice. The former two types of mice lack both IL-12 and
IL-23 functions, whereas the latter two lack only IL-12. ment of CD4 T cells to Th1 differentiation. Interestingly,
although IL-27 synergizes with IL-12 in inducing IFN-In general, the mice lacking only functional IL-12 are
more resistant to infections than those lacking both IL- production in human naive CD4 T cells and in NK cells
(Oppmann et al., 2000), IL-27, unlike IL-12 and IL-23,12 and IL-23, although they are often less resistant than
wild-type mice (Trinchieri, 2003). does not induce stable Th1 differentiation and priming
for IFN- production in human CD4 T cells (R. de WaalEven more striking results were reported in a Th1-
mediated autoimmune disease model, the experimental Malefyt and R.A.K., unpublished data). The major immu-
nological defect in EBI3/mice is a markedly decreasedautoimmune encephalomyelitis (EAE). Whereas EAE
could not be induced in IL-12 p40-deficient mice, the number in invariant natural killer T cells (iNKT) as defined
by staining with -galactosylceramide(GalCer)-loadeddisease was even more severe in p35- or IL-12R2-
deficient mice than in wild-type mice (Zhang et al., 2003). CD1d-tetramers (Nieuwenhuis et al., 2002). In response
to GalCer in vitro or in vivo, the EBI3/ mice producedThis suggested an essential role for IL-23 in EAE that
was fully confirmed in IL-23 p19-deficient mice, which much lower levels of IL-4 than wild-type mice, whereas
the production of IFN- was only moderately and tran-are completely resistant to EAE induction (Cua et al.,
2003). However, the generation of a Th1 response to siently lower than in wt mice. The requirement for IL-27
in the generation of iNKT may perhaps explain the lowermyelin oligodendrocyte glycoprotein in this model re-
quired IL-12 and not IL-23. IL-23-deficient mice showed level of IFN- produced by CD4 T cells from WSX-1/
mice in response to IL-12, a potent inducer of IFN-no disease but normal activation of Th1 cells. The ex-
pression of IL-23 was required in the CNS apparently in production in NKT cells. EBI3/ mice were resistant to
oxazolone-induced colitis, a model mediated preva-order to induce or maintain macrophage activation. IL-
23 in the CNS was produced both by microglia and lently by Th2 cytokine production initiated by iNKT cells,
whereas they were at least as susceptible as wild-typeactivated macrophages, but the IL-23 receptor complex
was expressed only on activated macrophages. Inter- mice to trinitrobenzene sulfonic acid-induced colitis, a
predominantly Th1-mediated colitis model. Two articlesestingly, IL-23 p19 has been shown to be highly ex-
pressed in sensory ganglia and CNS, either constitu- in this issue of Immunity (Hamano et al., 2003; Villarino
et al., 2003) show that, although WSX-1/ mice aretively or upon virus infection (Broberg et al., 2002). The
more severe disease in animals lacking IL-12 but not IL- able to mount a protective Th1 response to infection by
Toxoplasma gondii and Trypanosoma cruzi, the infected23, in the absence of optimal Th1 response, is probably
explained by the dual pathogenic and protective role of WSX-1/ mice show a much higher lethality compared
to wild-type mice or even IL-12p40/ mice, due to T cellIFN- in this disease. A very similar role for IL-12 and
IL-23 has been observed in the induction of another hyperactivity and enhanced production of proinflamma-
tory cytokines, including IFN-. These data suggest thatautoimmune disease, collagen-induced arthritis (C.A.
Murphy et al., submitted). In addition to a possible direct IL-27 not only is dispensable for the generation of Th1
responses in strongly polarizing conditions, but, likelyproinflammatory role, IL-23 may also promote a distinct
T cell activation state characterized by the production due to its ability to activate STAT1 and 3, also exerts a
powerful negative feedback mechanism that limits T cellof IL-17 (Aggarwal et al., 2003), a cytokine that has a
clear role in bone erosion and also may be involved in hyperactivity and IFN- production.
The present experimental evidence indicates that thetissue destruction in other autoimmune pathologies. It
is noteworthy that IL-12 antagonizes IL-23-induced IL- simple initial interpretation of IL-23 and IL-27 as copycat
cytokines sharing many functions with IL-12 and playing17 production by T cells, providing another possible
mechanism of the paradoxical protective effect of IL-12 similar roles but active at different times during the Th1
response needs a reevaluation. The biological functionsin autoimmunity. The use of p40 transgenic mice has
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27R (WSX-1) is required to suppress T cell hyperactivity duringof IL-12.
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